RADIATION THERAPY ONCOLOGY GROUP
RTOG 0126
A PHASE III RANDOMIZED STUDY OF HIGH DOSE 3D-CRT VERSUS STANDARD DOSE 3D-CRT IN PATIENTS TREATED FOR LOCALIZED PROSTATE CANCER
RTOG 0126
A PHASE III RANDOMIZED STUDY OF HIGH DOSE 3D-CRT VERSUS STANDARD DOSE 3D-CRT IN PATIENTS TREATED FOR LOCALIZED PROSTATE CANCER
Please note that RTOG 0126 has met its accrual objective and is closed to patient accrual as of Aug. 20, 2008.
Protocol Participation Information
- Credentialing
- Credentialing Requirements
- Dry Run Guidelines
- Facility Questionnaires: 3DCRT, IMRT
-
RPC Phantom Dosimetry Test (Prostate Phantom)
- Fill out the RPC Phantom Request Form to request shipment of a phantom.
- Contact Bill Straube at (314) 362-9762 regarding submission of phantom treatment planning data to the ITC.
- How to Participate
- Digital Data Submission Procedures
- Digital Data Submission Information (DDSI) Form
- Submission Check list
- ATC Compliant Treatment Planning Systems
- QA Guidelines (3DCRT)
- QA Guidelines (IMRT)
- QA Scoring Criteria
- Structure Names
- Contouring Examples
- Protocol Text (http://www.rtog.org/)
Back to protocols
